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http:WHAT THIS PAPER ADDS
Patients undergoing large abdominal operations, as well as alloplastic knee and hip joint replacement, are
recommended to continue antithrombotic prophylaxis for a period of 14e28 days following the surgery,
regardless of whether the patient stays in hospital or at home. In relation to applying antithrombotic pro-
phylaxis, vascular surgery seems to be an exception. This state of affairs may be surprising, as in the vast majority
of cases the patients operated on may be included in the moderate or high risk group in terms of developing
thromboembolic complications.Objective/background: In light of the methods generally used to assess the risk of venous thromboembolism
(VTE), major vascular operations should be regarded as high risk procedures. Nevertheless, no principles for
implementing and maintaining thromboprophylaxis have so far been developed. The aim of this study was to
determine the frequency and nature of VTE occurrence in patients routinely applying pharmacological
thromboprophylaxis following implantation of an aorto-bifemoral prosthesis.
Methods: The prospective non-randomized study included 105 patients with aortoiliac obstruction and 119
patients with abdominal aortic aneurysm (AAA) treated surgically. During hospitalization pharmacological
thromboprophylactic procedures were observed. A duplex test was performed on the day before surgery, on the
day of discharge, and 30 days after the patients had left the hospital.
Results: VTE was detected in 18.1% of the patients with aortoiliac obstruction (9.5% of patients during
hospitalization and 8.6% of patients after discharge). VTE was diagnosed in 21.0% of patients with AAA (15.1% of
patients during hospitalization and 5.9% of patients after discharge). The incidence of VTE was comparable in
both groups, both during hospitalization (p ¼ .51) and in the 30 day period following the end of hospitalization
(p ¼ .48). It is advisable that before hospital discharge routine duplex ultrasonography tests should be conducted
on the venous systems of all patients who have undergone major vascular operations.
Conclusions: It is likewise advisable to consider whether thromboprophylaxis for vascular patients should be
extended beyond their discharge from hospital.
 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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//dx.doi.org/10.1016/j.ejvs.2015.08.021following the surgery, whether they stay in hospital or at
home. This indication derives from the observation that
there is an increased frequency of venous thromboembo-
lism (VTE) developing in this patient group in the early post-
operative period.1
In the case of thromboprophylaxis, vascular surgery seems
to be an exception. This state of affairs may be surprising, as
in the vast majority of cases the patients operated on may be
included in moderate or high risk groups, in terms of devel-
oping VTE.2 The most important risk factors for VTE devel-
opment in this patient group include the following: advanced
Table 2. Frequency of risk factors for developing atherosclerosis
and thromboembolism (p < 0.05).
Risk factor Frequency (%) p
Group 1 Group 2
Tobacco smoking 49.52 36.14 <.01
Angina pectoris 29.52 31.93 .14
Post-infarction patient 27.62 29.41 .21
Hypertension 64.76 70.59 .87
Cerebral ischemia symptoms 12.38 16.81 .67
Diabetes 19.05 15.12 .01
Chronic obstructive
pulmonary disease
6.67 8.24 .87
Renal failure 3.81 1.68 .13
Neoplastic disease 7.61 10.08 .06
Necrotic lesions in limbs 34.62 0.84 <.01
Superﬁcial and/or deep
venous incompetence
8.78 5.88 .45
Presence of post-thrombotic
scars in superﬁcial and/or
deep veins
4.77 6.12 .35
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operative limb ischemia, revascularization syndrome,
considerable blood loss, the need for packed red blood cells
(PRBCs) and plasma transfusions, hypercoagulable state, vein
injuries, a history of thromboembolic episodes, limb edema
inhibiting venous outﬂow, and a lengthy period of immobi-
lization, which, on the one hand, is caused by the extent of
the surgery and, on the other, by the difﬁculty in obtaining
access to rehabilitation procedures.3,4
Few research studies are available and the considerable
diversity of their results have contributed to a limited
impact of the thromboprophylactic recommendations set
for vascular patients in the ninth edition of the antith-
rombotic guidelines issued by the American College of
Chest Physicians.5,6 According to these recommendations,
major vascular operations should be considered high risk
procedures in terms of VTE development. However, owing
to doubts regarding the research methodology, routine
application of thromboprophylaxis has been speciﬁed as a
level 1C recommendation.6
The purpose of the present study was to specify the
nature and frequency of VTE found in patients undergoing
major abdominal operations and those who are routinely
given pharmacological thromboprophylaxis.METHODS
The prospective non-randomized study included two
groups: group 1 included 105 patients (20 women, 85 men)
with aortoiliac obstruction; group 2 included 119 (15
women, 104 men) patients with abdominal aortic aneu-
rysms (AAA) and/or aneurysms of the iliac arteries.
The patients were treated surgically at the Department of
General and Vascular Surgery, Poznan Medical University, in
2014. The characteristics of the patients included in the
study are shown in Tables 1 and 2.Table 1. Pre-operative patient data and laboratory test results
(p < 0.05).
Group 1 Group 2 p
Age (y) 63.0  7.8 67.0  7.9 <.01
BMI 25.8  4.2 26.6  4.6 .02
Ejection fraction (%) 50.0  7.8 50.0  7.1 1.00
Hemoglobin (mmol/L) 8.5  1.2 8.8  1.1 1.00
Hematocrit (L/L) 0.41  0.05 0.42  0.30 1.00
Creatinine (mmol/L) 85.2  31.5 90.0  49.8 .03
Urea (mmol/L) 5.15  3.01 5.62  2.70 .45
ALAT (U/L) 23.5  22.5 20.5  15.1 .25
ASPAT (U/L) 21.0  34.4 21.0  16.7 .42
APTT (s) 32.2  6.5 32.6  8.8 .15
INR 1.00  0.13 1.0  0.3 .10
Thrombocytes (109/L) 251.0  97.0 207.0  80.4 <.01
Fibrinogen (mg/dL) 352.0  117.3 330.0  121.3 .09
Total cholesterol
(mmol/L)
4.74  1.40 4.78  1.20 .09
Triglycerides (mmol/L) 1.28  0.97 1.40  0.90 1.00
Note. Data are median  SD. BMI ¼ body mass index;
ALAT ¼ alanine transaminase; ASPAT ¼ glutamic oxoloacetic
transaminase; APTT ¼ activated partial thromboplastin time;
INR ¼ international randomized ratio.Exclusion criteria included: no consent given to partici-
pate in the study or to apply thromboprophylaxis using low
molecular weight heparin; urgent surgical procedures; his-
tory of heparin induced thrombocytopenia; long-term
antithrombotic drug administration; the patient left hospi-
tal without undergoing Duplex ultrasound (DUS); the pa-
tient died for reasons other than pulmonary embolism (PE)
before a DUS test could be performed on the venous sys-
tem; and the patient’s general status indicated little chance
of survival for >1 month.
The lower extremity veins were examined by means of
DUS.7 The tests were carried out by two vascular surgeons,
each with at least 15 years experience in the ﬁeld of DUS,
having performed >40,000 Doppler tests of the venous
system. The study equipment included a Mindrai DC-8 linear
probe operating at a frequency of 4e12 MHz and a convex
probe working at a frequency of 3e6 MHz. The iliac veins
were examined in the supine position.
The veins of the lower limbs were examined in the
standing position. Each time, the assessment covered the
common and external iliac veins, the femoral and deep
femoral veins, the popliteal vein, the anterior and posterior
tibial veins, and intramuscular veins of the gastrocnemius
calf muscle and the soleus muscle. Each vessel was exam-
ined in the transverse and longitudinal plane. Thrombosis
was diagnosed if echogenic structures were observed in the
veins that failed to collapse under probe pressure or veins
that failed to collapse under probe pressure. An additional
sign conﬁrming the diagnosis of thrombosis was no or
incomplete ﬁlling of the lumen with color. The latter
method formed the basis for the diagnosis of thrombosis in
the iliac veins. If in doubt, the patient’s examination was
carried out independently by both ultrasound specialists,
and, if necessary, it was repeated after 24 hours.
A DUS scan of the veins was routinely performed three
times, one day before the surgery, on the day of discharge,
and 30 days after discharge from hospital. Additional tests
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have indicated deep or superﬁcial vein thrombosis (SVT).
In the case of clinical symptoms that may have suggested
the presence of PE, the patient underwent computed to-
mography angiography of the chest.
All patients underwent implantation of a Dacron aorto-
bifemoral prosthesis via trans-abdominal access and
midline incision. Data regarding the surgical procedure (kind
of procedure; way the prosthesis was ﬁxed in place; the
surgical process) were obtained from the operation note.
Information on the duration of the surgical procedure, blood
loss volume, and the number of transfused PRBCs and
plasma units was obtained from anesthesiology reports.
Further treatment, taking into account any complications
and the possible need to perform subsequent procedures,
was determined on the basis of the medical documentation,
with particular attention paid to any observations made by
doctors and nurses, the results of diagnostic imaging and
laboratory tests, as well as descriptions of surgical procedures.Table 3. Parameters characterizing the surgery and post-operative
period in hospital (p < 0.05).
Group 1 Group 2 P
Surgery duration (min) 200.0  85.5 200.0  52.7 1.00
Blood loss (L) 0.4  1.3 0.8  0.8 <.01
PRBC transfusion (U) 2.0  3.7 2.0  2.3 .77
Blood plasma
transfusion (U)
0  2.0 0  1.5 .41
Stay in ICU (d) 2.0  6.1 0  1.1 .90
Stay in surgery ward (d) 6.0  3.6 6.0  3.2 1.00
Note. Data are median  SD. PRBC - packed red blood cells;
ICU ¼ intensive care unit.Thromboprophylaxis
All patients participating in the study received pharmaco-
logical thromboprophylaxis in accordance with the schedule
adopted by the Department of General and Vascular Sur-
gery. Because the catheter for epidural anesthesia was
applied 12 hours before the start of the surgery, no phar-
macological prophylaxis was used pre-operatively. During
the operation, just before aortic cross-clamping, each pa-
tient was administered an intravenous bolus of unfractio-
nated heparin (UFH) at a dose of 100 units per kg of body
mass. Throughout the period of aortic cross-clamping, the
value of the activated clotting time was maintained in the
range of 180e220 s. In the post-operative period, all pa-
tients were given subcutaneous low molecular weight
heparin (LMWH) (dalteparin 5,000 IU). The ﬁrst dose was
administered 6 hours after the end of the operation and
subsequent doses were administered every 24 hours. The
medication was continued until the end of hospitalization,
with periodic monitoring of the platelet count.
In the case of detection of SVT, the patients were treated
with a preventive LMWH dose for 30 days and were rec-
ommended to continue compression therapy with the use
of antithrombotic stockings (23 mmHg at the ankle). On
detection of DVT or PE, treatment was implemented with
the use of one of the two patterns: LMWH at a treatment
dose þ warfarin or rivaroxaban þ 2  15 mg until the 21st
day and then at a dose of 1  20 mg. The treatment was
continued for a period of 3e12 months.
No routine compression therapy was used. Only 12 pa-
tients from group 1 and 17 patients from group 2 who had
extensive varicose veins in the lower limbs used compression
therapy with short stretch bandages during hospitalization
(Rosidal K bands; Lohmann & Rauscher, Rengsdorf, Germany).
Each patient staying in the intensive care unit performed
isometric exercises. After being transferred to the surgical
department, each patient underwent intensive locomotor
rehabilitation, so as to be mobilized as soon as possible.Ethical approval statement
The institutional review board of Poznan University of
Medical Sciences granted the research study consent (No.
1083/13), and the patients provided their informed
consent.
Statistics
Statistical analyses were performed using Statistica 10
(StatSoft, Tulsa, OK, USA) and StatXact (Cytel, Cambridge,
MA, USA). A signiﬁcance level of p < .05 was adopted.
Comparison of non-normal variables measured on an
ordinal or interval scale was done using the ManneWhitney
test or KruskaleWallis analysis. Comparison of normally
distributed variables with equal variance measured on an
interval scale was done using Student t test for independent
samples; in the case of no homogeneity of variance, an
independent variance estimation test (the CochraneCox
test) was applied. To examine the correlation between the
variables measured on a nominal scale, the chi-square test
with Yates’s correction was employed together with the
FishereFreemaneHalton test.
RESULTS
The two groups differed in terms of age, body mass index,
smoking prevalence, diabetes, necrotic lesions on the lower
extremities, serum creatinine, and platelet count (Tables 1
and 2). The differences were due to the inclusion of all
patients who met the inclusion criteria and who underwent
surgery during the previous year, without randomization.
Data relating to the duration of the surgery, intra-
operative blood loss volume, the number of transfused
units of packed erythrocytes and plasma, and length of stay,
ﬁrst in intensive care and then in the surgical department,
are shown in Table 3. Differences were only observed in the
volume of blood lost, with twice as much blood being lost in
patients with aortic aneurysms.
Among the patients with aortoiliac obstruction, VTE
occurred in 19 individuals (18.1%) (10 [9.5%] during hos-
pitalization and 9 [8.6%] after the end of hospitalization)
(Table 4). A total of 12 of 17 cases of DVT involved calf
vessels; other cases related to the vessels in the iliofemoral
and popliteal sections. The symptoms that required differ-
entiation from venous thrombosis (swelling, tenderness
upon compression) occurred in 10 out of 17 patients with
Table 4. The type and incidence of thromboembolic complications during hospitalization and after discharge.
Study period
Group 1 (n ¼ 105) Group 2 (n ¼ 119)
Hospitalization After discharge Hospitalization After discharge
DVT 9 (8.3%) 8 (7.3%) 18 (15.1%) 7 (5.9%)
PE 2 (1.9%)
1  DVTþ
1  DVTe
1 (0.9%)
1  DVTe
2 (1.7%)
2  DVTþ
0 (0%)
Total number of patients with VTE episodes 10 (9.5%) 9 (8.6%) 18 (15.1%) 7 (5.9%)
Note. DVT ¼ deep vein thrombosis; PE ¼ pulmonary embolism; VTE ¼ venous thromboembolism; DVT(þ) ¼ PE in patients with DVT;
DVT() ¼ PE in patients without DVT.
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tient, SVT was diagnosed during hospitalization.
Among the group of patients with abdominal aortic an-
eurysms, VTE occurred in 25 individuals (21.0%) (including
18 [15.1%] during hospitalization and seven [5.9%] after
discharge) (Table 4). A total of 18 of 25 cases of DVT
involved calf vessels; other cases related to the vessels in
the iliofemoral and popliteal sections. The symptoms that
required differentiation from venous thrombosis (swelling,
tenderness upon compression) occurred in six out of 25
patients with DVT and in 21 out of 94 patients without DVT.
SVT was diagnosed after hospitalization in two patients.
The incidence of VTE was comparable in both groups,
both during hospitalization (p ¼ .51) and in the period of 30
days following the end of hospitalization (p ¼ .48) (Table 4).Table 5. Correlation between post-operative venous
thromboembolism (VTE) and other diseases (p < 0.05).
Comorbidities Group 1 Group 2
VTE þ VTEe p VTE þ VTEe p
% %
Angina pectoris 20.69 17.39 .70 16.22 25.00 .29
State after myocardial
infarction
25.00 15.71 .28 24.24 21.43 .74
Respiratory disorders 14.28 16.68 1.00 27.27 21.70 .35
Arterial hypertension 16.18 23.33 .39 20.73 25.71 .55
State after cerebral
stroke
33.33 17.24 .57 33.33 19.59 .19
Diabetes 12.50 19.51 1.00 37.50 20.00 .37
Renal insufﬁciency 25.00 18.09 .76 50.00 21.74 .92
Neoplastic disease 25.00 17.78 .38 0.00 24.53 .24
Necrotic lesions 37.50 9.23 <.01 0.00 22.61 .51
Presence of
post-thrombotic scars
in superﬁcial and/or
deep veins
12.50 18.89 .63 46.15 19.23 .02
Note. VTE(þ) ¼ patients with post-operative VTE;
VTE() ¼ patients without post-operative VTE.Determining the relationship between the occurrence of
VTE and other parameters under study
In the case of patients with aortoiliac obstruction, VTE was
signiﬁcantly more common in elderly patients, and patients
with necrotic lesions present in their limbs, with lower
hemoglobin and ﬁbrinogen concentrations, higher platelet
counts, more erythrocyte units transfused, and more days
spent in the intensive care unit (Tables 5 and 6).
With regard to patients with AAA (group 2), a signiﬁcantly
higher incidence of VTE was observed after previous epi-
sodes of venous thromboembolic disease and a longer post-
operative stay in the surgical department (Tables 5 and 6).
Other risk factors present in the pre-operative period, the
results of laboratory tests, the course of the surgery, and
the post-operative period did not correlate with the fre-
quency of VTE (Tables 5 and 6).
DISCUSSION
In a study of 69 patients following surgical procedures in the
aortofemoral section, Satiani et al. did not observe a single
case of VTE.8 In the study of Saarinen et al.,9 analyzing the
statistical data from the FINNVASC database, the frequency
of VTE was determined to be 0.5%. The paper did not
include any additional, speciﬁc research into DVT.9 Killewich
et al. observed venous thrombosis in 2% of patients using
or not using pharmacological thromboprophylaxis.10 How-
ever, in other research, Saarinen et al. ignored the di-
agnostics of crural veins which, according to the
observations of the authors of the present study, consti-
tuted the most frequent location of thrombotic lesions.Thus, the numbers provided by Killewich et al. should rather
be considered as describing the frequency of proximal
thrombosisdthis value is similar to that obtained in the
present analysis.10 In another study, applying various forms
of prophylaxis, Farkas et al. determined the frequency of
VTE as 4.2% and 10.6%, depending on the administration of
UFH and LMWH,11 respectively, whereas with Fletcher and
Batiste, who applied UFH and compression therapy, the VTE
frequency was 11.5%.12
In the case of surgical procedures in the aortoiliac and
femoral sections, in which no thromboprophylaxis was
used, the frequency of VTE was greater than in the patients
who received prophylaxis, and amounted 18e27%.13e15
As opposed to the aforementioned research papers, the
highest frequency of VTE occurrence was noted by
Hamer16; being 42% in the case of patients operated on in
the femoropopliteal section. Among all the researchers
conducting prospective studies, Hamer was the only one to
apply phlebography in the diagnostics. Regardless of the
fact that the study included only those patients who did not
apply any form of prophylaxis, the result may arise from
using the most sensitive diagnostic method.17,18
In the present study, the thrombotic lesions in the vast
majority of the cases were located in the intramuscular
Table 6. Correlation between post-operative venous thromboembolism (VTE) and the tested parameters (p < 0.05).
Risk factor Group 1 Group 2
VTEþ VTEe p VTEþ VTEe p
Age (y) 68.0  6.6 62.0  7.9 <.01 71.0  7.3 67.0  8.1 .08
Hemoglobin (mmol/L) 7.7  1.4 8.6  1.1 .03 8.9  1.5 8.7  1.1 .96
Fibrinogen (mg/dL) 407  143 336  103 <.01 329  113 328  125 .37
Thrombocytes (109/L) 307  132 237  80 <.01 210  81 200  82 .14
PRBC transfusion (U) 3.5  3.9 0.0  2.0 .04 2.0  2.5 2.0  2.3 .08
Stay in ICU (d) 2.0  9.2 2.0  3.1 .02 2.0  1.6 2.0  1.1 .52
Stay in surgery ward (d) 7.78  5.15 6.05  2.59 .31 7.00  4.20 6.00  2.80 .02
Note. Data are median  SD. VTE(þ) ¼ patients with post-operative VTE; VTE() ¼ patients without post-operative VTE; PRBC ¼ packed
red blood cells; ICU ¼ intensive care unit.
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mius muscle.
The earlier research papers provide various data
regarding the frequency of particular DVT locations. In a
research study conducted by Hollyoak et al.,19 thrombosis
pertained to the peripheral veins in 80% of cases, and to the
veins within the femoropopliteal section in 20% of cases. In
other authors’ studies the above ratio moved gradually in a
proximal direction, amounting to 78% and 22%, 67% and
33%, 52% and 48% for the distal and proximal sections,
respectively.13,14,20 Fletcher and Batiste observed proximal
thrombosis in as many as 80% of patients with VTE,12
whereas Killewich et al. detected the presence of
thrombus only in the proximal veins.10 However, according
to the examination report, the lower leg veins were not
assessed with a DUS scan.
In the present study, a correlation between the occur-
rence of VTE and other factors was observed. With regard
to the values speciﬁed in the pre-operative period, a cor-
relation was observed in the cases of age, necrotic lesions in
limbs, hemoglobin and ﬁbrinogen content, and platelet
count. With regard to the parameters connected to the
peri- and post-operative periods, correlations were
observed in the cases of the number of transfused PRBC
units, as well as the length of stay in the intensive care unit.
Patient immobilization is commonly considered to be a
potential factor in the development of DVT and/or PE. This
parameter is not always deﬁned so strictly as to mean a
patient’s total inability to move. Some authors interpret it
as the ability of the patient to walk painlessly for <50 m.
However, in the case of vascular patients, this factor only
occurs in principle in the pre-operative period, and
following successful revascularization it subsides in the
post-operative period.5
Based on the present results, it is proposed that immo-
bilization should also, or even ﬁrst and foremost, be deﬁned
to include the presence of any necrotic lesions in the limbs.
Their clearing and healing may be a factor that signiﬁcantly
hinders the mobilization of patients in the post-operative
period.
It is unclear whether there is a connection between a
history of thrombotic episodes and VTE development in the
post-operative period. The present study did not show any
correlation between these. However, it is generally assumed
that the presence of residual thrombus constitutes a riskfactor for another thrombotic episode.6,21 In fear of an
increased risk of VTE, Passman et al. excluded any patients
with old ﬁbrous thrombi in the lower limb veins, as well as
patients with conﬁrmed coagulation disorders.20 In turn,
Hollyoak et al. did not observe any new thrombi forming in
patients with residual thrombus in the lower limb veins.19
However, drawing any conclusions from this fact would
not be justiﬁable in the present study, as such old post-
thrombotic lesions were found in one patient only.
The presence of varicose veins or postthrombotic scars in
deep or superﬁcial veins did not inﬂuence the incidence of
postoperative VTE in this study. This may be explained by
the fact that short-stretch bandages were consequently
used in all these patients. Previous studies have shown that
a simultaneous combination of heparin and compression
therapy reduces the risk of thrombotic complications more
than the use of heparin or compression therapy alone.22
As the group of patients with atherosclerotic ischemia of
the lower extremities may cause doubts as to the safety of
elastic bandages or stockings, using intermittent pneumatic
compression therapy should be considered instead. On the
one hand, it was demonstrated that the method is useful in
reducing the incidence of thrombotic complications in the
group of orthopedic and intensive care unit patients. It is
the method of choice in patients at high risk for developing
thrombotic and hemorrhagic complications. On the other
hand, the use of intermittent compression is associated
with the ability to improve skin perfusion in patients with
ischemic limbs, which signiﬁcantly reduces the risk of local
complications and speeds up the healing of ischemic
ulcerations.22,23
The present study did not show any impact of sex on the
frequency of VTE occurrence. The observations of Saarinen
et al. suggest the opposite.9 No correlation was found be-
tween the development of post-operative thrombosis and
concomitant diseases, the location of revascularization
(abdominal cavity, lower extremities), or the nature of the
procedure (primary, secondary or urgent reconstruction, re-
operation).
CONCLUSIONS
Despite the routine application of pharmacological throm-
boprophylaxis, a population of patients undergoing major
revascularization procedures in the aortoiliac-femoral sec-
tion had a considerable risk of developing VTE, among
126 K. Pawlaczyk et al.which the peripheral form of DVT was the most prevalent.
In three of ﬁve cases, VTE developed during hospitalization,
when thromboprophylaxis was applied. The remaining two
cases occurred in the post-hospitalization period. The vast
majority of the thrombosis episodes were asymptomatic.
In view of the above, whether it is advisable to conduct
routine DUS tests of the venous system in all patients who
have undergone major vascular operations before hospital
discharge, needs to be considered so as to detect any
asymptomatic cases of venous thrombosis, and to deter-
mine whether it is advisable to continue the application of
thromboprophylaxis in vascular patients following hospital
discharge.
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